UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

Patient-centered applications: use of information technology to promote disease management and wellness. A white paper by the AMIA knowledge in motion working group

Journal of the American Medical Informatics Association : JAMIA, 2008-01, Vol.15 (1), p.8-13

2008

Volltextzugriff (PDF)

Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness

Naunyn-Schmiedeberg's archives of pharmacology, 2020-09, Vol.393 (9), p.1573-1580

2020

Volltextzugriff (PDF)

Nonhistaminergic idiopathic angioedema may be a presentation of mast cell activation syndrome

Journal of investigational allergology & clinical immunology, 2013, Vol.23 (3), p.212-212

Afrin, L B

2013

Volltextzugriff (PDF)

Mast cell disorders in Ehlers–Danlos syndrome

American journal of medical genetics. Part C, Seminars in medical genetics, 2017-03, Vol.175 (1), p.226-236

2017

Volltextzugriff (PDF)

Mast Cell-Mediated Mechanisms of Nociception

International Journal of Molecular Sciences, 2015-12, Vol.16 (12), p.29069-29092

2015

Volltextzugriff (PDF)

Pharmacological treatment options for mast cell activation disease

Naunyn - Schmiedeberg's Archives of Pharmacology, 2016-07, Vol.389 (7), p.671-694

2016

Volltextzugriff (PDF)

Masitinib dans le traitement de la mastocytose systemique sévère de forme indolente ou latente : un essai clinique de phase 3 randomisé et controllé

Annales de dermatologie et de vénéréologie, 2016-12, Vol.143 (12), p.S188-S189

2016

Volltextzugriff (PDF)

Race, education, and knowledge of bone marrow registry: Indicators of willingness to donate bone marrow among African Americans and Caucasians

Transplantation proceedings, 2004-12, Vol.36 (10), p.3212-3219

2004

Volltextzugriff (PDF)

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

Haematologica (Roma), 2015-09, Vol.100 (9), p.1139

2015

Volltextzugriff (PDF)

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

Haematologica (Roma), 2015-04, Vol.100 (4), p.479

2015

Volltextzugriff (PDF)

Polycythemia From Mast Cell Activation Syndrome: Lessons Learned

The American journal of the medical sciences, 2011-07, Vol.342 (1), p.44-49

2011

Volltextzugriff (PDF)

Electronic clinical trial protocol distribution via the World-Wide Web: a prototype for reducing costs and errors, improving accrual, and saving trees

Journal of the American Medical Informatics Association : JAMIA, 1997-01, Vol.4 (1), p.25-35

1997

Volltextzugriff (PDF)

Web Access to the American Society of Hematology Slide Bank

Blood, 1999-04, Vol.93 (7), p.2425-2426

Afrin, Lawrence B.

1999

Volltextzugriff (PDF)

Fentanyl‐Associated Syndrome of Inappropriate Antidiuretic Hormone Secretion

Pharmacotherapy, 2002-09, Vol.22 (9), p.1188-1192

2002

Volltextzugriff (PDF)

Serum C 18 -ceramide as a biomarker for response: Phase II trial of gemcitabine plus doxorubicin in patients with HNSCC

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5590-5590

2011

Volltextzugriff (PDF)

Expression of ricin B chain in Spodoptera frugiperda

Biochemical journal, 1994-11, Vol.303 (3), p.787-794

1994

Volltextzugriff (PDF)

Case Report: Treatment of systemic mastocytosis with sunitinib

F1000 research, 2017, Vol.6, p.2182-2182

2017

Volltextzugriff (PDF)

Reproductive Health Problems in Adolescent Female Garment Workers of Dhaka City

Bangladesh medical journal, 2014-05, Vol.41 (1), p.25-27

2014

Volltextzugriff (PDF)

Medical therapy of prostate cancer: 1999

Journal of the South Carolina Medical Association, 2000-02, Vol.96 (2), p.77

2000

Volltextzugriff (PDF)

Web Access to the American Society of Hematology Slide Bank

Blood, 1999-04, Vol.93 (7), p.2425-2426

Afrin, Lawrence B.

1999

Volltextzugriff (PDF)

Expression of Oligohistidine-Tagged Ricin B Chain in Spodoptera frugiperda

Bioconjugate chemistry, 1994-11, Vol.5 (6), p.539-546

1994

Volltextzugriff (PDF)

ANTIVIRAL EFFECTS OF BACTERIOCIN AGAINST ANIMAL-TO-HUMAN TRANSMITTABLE MUTATED SARS-COV-2: A SYSTEMATIC REVIEW

Frontiers of agricultural science and engineering, 2021-12, Vol.8 (4), p.603-622

2021

Volltextzugriff (PDF)

Medical therapy of prostate cancer

Journal of the South Carolina Medical Association, 1994-05, Vol.90 (5), p.231

1994

Volltextzugriff (PDF)

Improving oversight of the graduate medical education enterprise: one institution's strategies and tools

Academic medicine, 2006-05, Vol.81 (5), p.419-425

2006

Volltextzugriff (PDF)

Primary mediastinal large B-cell lymphoma

Southern medical journal (Birmingham, Ala.), 2002-09, Vol.95 (9), p.1005-1007

2002

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Patient-centered applications: use of information technology to promote disease management and wellness. A white paper by the AMIA knowledge in motion working group

Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness

Nonhistaminergic idiopathic angioedema may be a presentation of mast cell activation syndrome

Mast cell disorders in Ehlers–Danlos syndrome

Mast Cell-Mediated Mechanisms of Nociception

Pharmacological treatment options for mast cell activation disease

Masitinib dans le traitement de la mastocytose systemique sévère de forme indolente ou latente : un essai clinique de phase 3 randomisé et controllé

Race, education, and knowledge of bone marrow registry: Indicators of willingness to donate bone marrow among African Americans and Caucasians

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

Polycythemia From Mast Cell Activation Syndrome: Lessons Learned

Electronic clinical trial protocol distribution via the World-Wide Web: a prototype for reducing costs and errors, improving accrual, and saving trees

Web Access to the American Society of Hematology Slide Bank

Fentanyl‐Associated Syndrome of Inappropriate Antidiuretic Hormone Secretion

Serum C 18 -ceramide as a biomarker for response: Phase II trial of gemcitabine plus doxorubicin in patients with HNSCC

Expression of ricin B chain in Spodoptera frugiperda

Case Report: Treatment of systemic mastocytosis with sunitinib

Reproductive Health Problems in Adolescent Female Garment Workers of Dhaka City

Medical therapy of prostate cancer: 1999

Web Access to the American Society of Hematology Slide Bank

Expression of Oligohistidine-Tagged Ricin B Chain in Spodoptera frugiperda

ANTIVIRAL EFFECTS OF BACTERIOCIN AGAINST ANIMAL-TO-HUMAN TRANSMITTABLE MUTATED SARS-COV-2: A SYSTEMATIC REVIEW

Medical therapy of prostate cancer

Improving oversight of the graduate medical education enterprise: one institution's strategies and tools

Primary mediastinal large B-cell lymphoma

Suchergebnisse filtern